(Adds details in paragraphs 2 to 4) Nov 18 (Reuters) – The US Food and Drug Administration has approved Regeneron Pharmaceuticals' drug to treat adults with a type of rare autoimmune disease called
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By David Shepardson and Rishabh Jaiswal WASHINGTON, Nov 18 (Reuters) - Democratic lawmakers have opened…
By Echo Wang NEW YORK, Nov 18 (Reuters) - Anthropic’s IPO raised $81.31 billion on…
Nov 19 (Reuters) - EchoIQ Ltd: * TRADING HALT PENDING MATERIAL ANNOUNCEMENT ON REGULATORY PATHWAY…
(Repeats to widen distribution, no change to text) By Jarrett Renshaw and Steve Holland SHENZHEN,…
By Ismail Shakil Nov 18 (Reuters) - A US House panel asked Microsoft on Wednesday…
By Ismail Shakil Nov 18 (Reuters) - A US House panel asked Microsoft on Wednesday…